FX140. Study Investigators. A randomized study comparing the efficacy and safety of nadroparin 2850 IV (0.3 mL) versus enoxaparin 4000 IV (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer - Simmonneau, G; Laporte, S; Mismetti, P (J Thromb Haemost, 2006)
et al.